Bots, editor, reviewer, Administrators
13,941
edits
No edit summary |
No edit summary |
||
Line 3,650: | Line 3,650: | ||
"title" : "The Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure", | "title" : "The Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure", | ||
"pmid" : "17384437" | "pmid" : "17384437" | ||
}, | |||
{ | |||
"timestamp" : "2024-06-27T19:03:26Z", | |||
"briefDesignDescription" : "TAVR in low-risk patients", | |||
"fulltexturl" : "https://www.nejm.org/doi/full/10.1056/NEJMoa1816885", | |||
"pageid" : 4061, | |||
"pdfurl" : "https://www.nejm.org/doi/pdf/10.1056/NEJMoa1816885", | |||
"trainingLevel" : "resident", | |||
"citation" : "Popma JJ, <i>et al</i>. \"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients\". <i>The New England Journal of Medicine</i>. 2019. 380(18):1706-1715.", | |||
"subspecialties" : "Cardiology", | |||
"expansion" : "", | |||
"statusUsableDate" : "2024-06-27", | |||
"briefResultsDescription" : "TAVR non-inferior to surgery at 24 months in low-risk patients", | |||
"published" : "2019-05-02", | |||
"pageName" : "Evolut Low Risk", | |||
"diseases" : "Aortic Stenosis", | |||
"abbreviation" : "", | |||
"title" : "Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients", | |||
"pmid" : "30883053" | |||
}, | }, | ||
{ | { |